BLOOMFIELD, Conn., Jan. 13, 2025 /PRNewswire/ -- Cigna Healthcare, the health benefits division of The Cigna Group (NYSE: CI), today announced a new offering in collaboration with Progyny, Inc (Nasdaq: PGNY) that makes best-in-class fertility and family-building services accessible and equitable for more employers. This new and comprehensive benefit will enable employers to offer expanded coverage throughout the entire fertility journey, from pre-conception planning to postpartum care, along with coverage o ...

Job Market Performance - US companies added 256,000 jobs last month, significantly exceeding the market expectation of 155,000 job gains [2] Investment Research Platform - iREIT on Alpha offers in-depth research on REITs, mREITs, Preferreds, BDCs, MLPs, ETFs, and other income alternatives [2] - The platform has received 438 testimonials, with most being 5-star reviews [2] - A free 2-week trial is available for potential users [2]

A few years ago, when Virta Health founder and CEO Sami Inkinen approached employers about leveraging the company's nutrition-oriented digital diabetes program for obesity-related weight loss, most companies weren't ready to commit. Now, more employers are all in on nutritional counseling and coaching as they grapple with rising costs for diabetes and weight loss drugs like Novo Nordisk's Ozempic and Wegovy and Eli Lilly's Mounjaro and Zepbound. "Our goal is not to drive the maximum number of GLP-1 prescrip ...

BLOOMFIELD, Conn., Jan. 8, 2025 /PRNewswire/ -- The Cigna Group Foundation announced today 22 recipients for the first year of its new grant program that aims to improve veteran mental health with a focus on housing stability. Through this initiative, The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), is allocating $9 million over the next three years as part of its continuing focus on veteran well-being. Volunteers from The Cigna Group install a fence with Veterans Communit ...

Shares of The Cigna Group (CI) have plunged 18.7% in the past three months, underperforming the industry’s decline of 12%. Peers like Centene Corporation (CNC) and Humana Inc. (HUM) have lost 12.1% and gained 8.7%, respectively, over the same time frame.The S&P 500 Composite has returned 4.8% over the same period, highlighting a divergence in performance. The stock is currently trading below its 50-day and 200-day moving average, signaling potential downward momentum.CI's 3-Month Price Performance Compariso ...

The health insurance industry has received a lot of backlash over its managed care practices that bog down providers with pre-authorizations and rampant medical claim denials. The rise in medical benefits ratios (MBRs) driven by Medicare Advantage plans have squeezed margins for major health insurance providers like Humana Inc. NYSE: HUM, UnitedHealth Group Inc. NYSE: UNH, and CVS Health Co. NYSE: CVS. However, one major insurer saw the writing on the wall early on and divested its Medicare Advantage busine ...

Cigna (CI) shares ended the last trading session 6.3% higher at $282.41. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 17.7% loss over the past four weeks.Cigna’s recent price movement stems from recovering investor confidence in the prospects of the company after an overreaction by investors to the new resolution targeting pharmacy benefit managers. These provisions were initially feared to impose stringent regu ...

It's often said that death and taxes are the only two certainties in life. However, I'd add another: In the stock market, volatility is a fact of life. That is because it's important to remember thatThis article was co-produced with Kody Kester.Introducing iREIT®Join iREIT® on Alpha today to get the most in-depth research that includes REITs, mREIT, Preferreds, BDCs, MLPs, ETFs, Builders, and Asset Managers. Our iREIT® Tracker provides data on over 250 tickers with our quality scores, buy targets, and trim ...

UnitedHealth Group signage is displayed on a monitor on the floor of the New York Stock Exchange.Shares of major health-care companies fell as much as 5% on Wednesday as investors feared pressure from lawmakers and patients could force changes to their business models.The declining stocks include UnitedHealth Group, Cigna and CVS Health, which operate three of the nation's largest private health insurers and drug supply chain middlemen called pharmacy benefit managers, or PBMs. They also own pharmacy busine ...

Core Viewpoint - Cigna Group is experiencing strong growth driven by solid pharmacy revenues, a robust medical customer base, strategic acquisitions, and a strong financial position, with optimistic guidance for 2024 acting as a tailwind [1][7]. Financial Performance - Cigna's stock has increased by 17.1% over the past year, outperforming the industry growth of 6.9% [3]. - The Zacks Consensus Estimate for Cigna's 2024 earnings is $28.50 per share, reflecting a 13.6% increase from the previous year, with revenues projected at $243.8 billion, indicating a 24.8% rise [5]. - For 2025, earnings are estimated at $31.59 per share, showing a 10.9% growth from 2024, with revenues expected to reach $249.8 billion, a 2.5% increase from the 2024 estimate [5]. Growth Drivers - Cigna's growth is supported by two main platforms: Evernorth and Cigna Healthcare, with management expecting average annual adjusted earnings per share growth of 10-14% in the long term [8]. - Evernorth's specialty pharmacy services have led to a 35% year-over-year increase in pharmacy revenues in the first nine months of 2024 [9]. - Cigna Healthcare benefits from a large customer base in U.S. Healthcare operations, with projected long-term earnings growth of 7-10% and strong demand for Medicare plans due to an aging population [10]. Strategic Initiatives - Cigna is focused on product innovation, collaborations, and strategic acquisitions to enhance capabilities and market presence, while divesting non-health-related units to concentrate on high-growth areas [11]. - The company has robust cash reserves and projects operating cash flows of approximately $60 billion over the next five years, allowing for business expansion and shareholder returns through dividends and share repurchases [12]. Dividend and Shareholder Returns - Cigna approved a 14% increase in its quarterly dividend, with a current dividend yield of 1.7%, higher than the industry average of 1.4% [12].